Search Results

This article explores how Revvity Signals Solutions are transforming drug discovery by addressing inefficiencies in pharma and biotech workflows.

This article discusses how digital transformation is enhancing R&D efficiency in the pharmaceutical and chemical industries.

This article discusses the role of digital tools like the Signals Research Suite in optimizing biosimilar development by streamlining data capture, analysis, and collaboration.

This article explores how AI and ML are revolutionizing drug discovery by enhancing data accessibility, automating chemical reaction recommendations, and improving cellular imaging.

This article highlights the critical role of an AI-ready data strategy in drug discovery, emphasizing that AI is only as effective as the quality of data it processes.

This article highlights the importance of unifying and contextualizing drug discovery data to harness the full potential of advanced analytics.

We recently launched Signals Image Artist™ the fast, efficient image analysis and data management solution for High Content Screening and cellular image data that integrates with Revvity Signals Signals™ VitroVivo for secondary data analysis. High Content Screening is a mainstream technology for drug research. More and more experiments are run on more and...

This article highlights the role of data strategies in accelerating the development of new drug modalities